Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Biomed Res Int ; 2017: 8796760, 2017.
Article in English | MEDLINE | ID: mdl-29090221

ABSTRACT

The role of type I IFNs in the pathogenesis and control of mycobacterial infection is still controversial. It has been reported that type I IFNs exacerbated M. tuberculosis infection through hampering Th1 type cellular immune response. However, under certain conditions they can act as natural immune adjuvants for commercial vaccines. At this point, we have reported recently that successive IFN-alpha boosting of Mycobacterium bovis Bacillus Calmette Güerin (BCG) vaccinated mice protected adult mice from intradermal M. lepraemurium infection and a difference in iNOS was observed. In the present work, we have found that intramuscular IFN-α boosting of Mycobacterium bovis Bacillus Calmette Güerin (BCG) vaccine, either in vitro (human cell line or macrophages derived from PBMC) or in vivo (aerosol mouse model of MTb infection), promoted mostly the development of specific anti-antimycobacterial Th1 type cytokines (IFN-γ; IL-12, TNF-alpha, and IL-17; IL1ß) while bacterial load reduction (0.9 logs versus PBS or BCG vaccine) was observed. These findings indicate that, under the experimental settings reported here, interferon alpha can drive or affect the TH cellular immune response in favour of BCG-inducing immunity against M. tuberculosis infection.


Subject(s)
Immunity, Cellular/drug effects , Immunization, Secondary , Interferon-alpha/pharmacology , Mycobacterium bovis/immunology , Mycobacterium tuberculosis/immunology , Th1 Cells/immunology , Tuberculosis/prevention & control , Animals , Interferon-alpha/immunology , Mice , Mice, Inbred BALB C , Th1 Cells/pathology , Tuberculosis/immunology , Tuberculosis/pathology
2.
Biomed Res Int ; 2015: 414027, 2015.
Article in English | MEDLINE | ID: mdl-26484351

ABSTRACT

Leprosy caused by Mycobacterium leprae primarily affects the skin and peripheral nerves. As a human infectious disease, it is still a significant health and economic burden on developing countries. Although multidrug therapy is reducing the number of active cases to approximately 0.5 million, the number of cases per year is not declining. Therefore, alternative host-directed strategies should be addressed to improve treatment efficacy and outcome. In this work, using murine leprosy as a model, a very similar granulomatous skin lesion to human leprosy, we have found that successive IFN-alpha boosting protects BCG-vaccinated mice against M. lepraemurium infection. No difference in the seric isotype and all IgG subclasses measured, neither in the TH1 nor in the TH2 type cytokine production, was seen. However, an enhanced iNOS/NO production in BCG-vaccinated/i.m. IFN-alpha boosted mice was observed. The data provided in this study suggest a promising use for IFN-alpha boosting as a new prophylactic alternative to be explored in human leprosy by targeting host innate cell response.


Subject(s)
BCG Vaccine/therapeutic use , Interferon-alpha/therapeutic use , Mycobacterium Infections/drug therapy , Mycobacterium Infections/prevention & control , Mycobacterium lepraemurium , Animals , BCG Vaccine/administration & dosage , Injections, Intramuscular , Interferon-alpha/administration & dosage , Mice
3.
Hypertens Pregnancy ; 33(2): 191-203, 2014 May.
Article in English | MEDLINE | ID: mdl-24295154

ABSTRACT

OBJECTIVE: To evaluate the peripheral blood mononuclear cell (PBMC) expression levels of hemeoxygenase 1 (HMOX-1), superoxide dismutase 1 (SOD-1), vascular endothelial growth factor A (VEGF-A), transforming growth factor beta 1 (TGF-ß1), interleukin (IL)-6, IL-15 and AdipoQ genes to study their association with preeclampsia (PE). METHODS: A total of 177 pregnant women were recruited: 108 cases and 69 controls. Quantification of gene expression was measured by quantitative real-time polymerase chain reaction (PCR) using TaqMan probes. RESULTS: Underexpression of VEGF-A and TGF-ß1 was a constant in most of the cases (80.91% and 76.36%, respectively) and their expression was associated with onset and/or severity of disease (p values < 0.05). IL-6, IL-15 and AdipoQ, showed low or no expression in PBMC samples evaluated. CONCLUSION: PBMC underexpression of VEGF-A and TGF-ß1 is a hallmark of PE in the study population.


Subject(s)
Biomarkers/metabolism , Leukocytes, Mononuclear/metabolism , Pre-Eclampsia/metabolism , Adiponectin/metabolism , Adolescent , Adult , Case-Control Studies , Female , Heme Oxygenase-1/metabolism , Humans , Interleukin-15/metabolism , Interleukin-6/metabolism , Pre-Eclampsia/genetics , Pregnancy , Superoxide Dismutase/metabolism , Superoxide Dismutase-1 , Transforming Growth Factor beta1/metabolism , Vascular Endothelial Growth Factor A/metabolism , Young Adult
4.
Clin Dev Immunol ; 2011: 730702, 2011.
Article in English | MEDLINE | ID: mdl-21647410

ABSTRACT

Heterologous prime-boost regimens are effective strategies to promote long-term memory and strong cellular Th1 responses to Mycobacterium tuberculosis, when BCG is used in the priming step. Subcutaneous or intranasal boosting of BCG-vaccinated newborn mice with native heparin-binding haemagglutinin (nHBHA) significantly enhances protection against M. tuberculosis. However, nHBHA is characterized by a complex methylation pattern in its C-terminal domain, which is important for protective immunogenicity in primary vaccination. In this study we addressed the question whether boosting with recombinant, non-methylated HBHA (rHBHA) produced in Escherichia coli may enhance protection of BCG-primed newborn mice. We found that while subcutaneous rHBHA boosting enhanced protection of BCG-primed mice against intranasal M. tuberculosis infection both in spleen and lungs, enhanced protection against aerosol infection was only seen in the spleen (0.72 logs; P < 0.05) but not in the lungs. Thus, in BCG-primed mice the methylation of the C-terminal domain of HBHA is dispensable for the induction of enhanced protection in the lungs against intranasal but not aerosol infection, whereas it enhances protection in the spleen in both challenge models. This report thus provides evidence that rHBHA may be considered as a booster vaccine against disseminated tuberculosis.


Subject(s)
BCG Vaccine , Lectins/immunology , Mycobacterium tuberculosis/immunology , Tuberculosis Vaccines , Tuberculosis/prevention & control , Animals , Animals, Newborn , Antigens, Bacterial/immunology , BCG Vaccine/immunology , Immunization, Secondary , Lectins/genetics , Mice , Spleen/immunology , Spleen/microbiology , Tuberculosis/immunology , Tuberculosis/microbiology , Tuberculosis Vaccines/administration & dosage , Tuberculosis Vaccines/immunology , Vaccines, Synthetic/administration & dosage , Vaccines, Synthetic/immunology
5.
Scand J Immunol ; 66(6): 610-8, 2007 Dec.
Article in English | MEDLINE | ID: mdl-17949406

ABSTRACT

The N-terminal half or toxic fragment of Bacillus thuringiensis Cry proteins is comprised of three structural domains. In a previous paper, we showed that this region plays an important role in the immunogenicity of the B. thuringiensis Cry proteins. Due to this ability and along with their stability it is worthy of investigating whether this region has carrier potential. To approach this, an eight amino acid hydrophobic motif in alpha-helix 7 of wild-type (WT) Cry1A toxins was exchanged for a diphtheria toxin epitope (DTB). The resultant recombinant toxins were tested for their ability to induce specific anti-Cry and anti-diphtheria toxin antibodies in mice after intraperitoneal and nasal immunization. We found that recombinant Cry1A toxins retained their ability to induce serum and mucosal anti-Cry Ab as well as IgG subclasses, although with a varied magnitude. By the systemic route, the effect of the amino acid substitution in the ratio of the IgG1/IgG2a Ab, leading in some sites toward IgG1 or IgG2a is more evident. Interestingly, mice produced specific anti-DTB IgG, and IgA after intranasal immunization. Together, our results support and show the immunogenic properties of the WT Cry1A toxins as well as its carrier potential for a DTB.


Subject(s)
Bacterial Proteins/genetics , Bacterial Proteins/immunology , Bacterial Toxins/genetics , Bacterial Toxins/immunology , Carrier Proteins/immunology , Diphtheria Toxin/immunology , Endotoxins/genetics , Endotoxins/immunology , Epitopes/genetics , Hemolysin Proteins/genetics , Hemolysin Proteins/immunology , Administration, Inhalation , Amino Acid Motifs/genetics , Amino Acid Motifs/immunology , Amino Acid Substitution/genetics , Amino Acid Substitution/immunology , Animals , Antibody Formation , Bacillus thuringiensis Toxins , Carrier Proteins/genetics , Diphtheria Toxin/administration & dosage , Diphtheria Toxin/genetics , Epitopes/immunology , Immunization , Immunoglobulin A/biosynthesis , Immunoglobulin G/biosynthesis , Injections, Intraperitoneal , Male , Mice , Mice, Inbred BALB C , Recombinant Fusion Proteins/genetics , Recombinant Fusion Proteins/immunology
6.
Mol Immunol ; 44(6): 1209-17, 2007 Feb.
Article in English | MEDLINE | ID: mdl-16930715

ABSTRACT

Insecticidal Cry1A toxins from Bacillus thuringiensis elicit strong humoral immune response in mice. Previously, we showed that an eight hydrophobic motif amino acid substitution in Domain I did not affect the antibody inducing capacity of the Cry1A toxins, on the contrary, it was enhanced after intranasal immunization. In addition, Cry1A mutants (carrying a substitution of a motif from fragment B of diphtheria toxin into the structurally similar hydrophobic alpha-helix 7 motif of Cry1A toxins) were able to modulate the ratio of IgG subclasses, IgG1/IgG2a. However, the capacity of these toxins to induce cellular immune response has not been studied. Thus, in this work, we investigated the cytokine profile induced after in vitro stimulation with the toxins, in spleen cell cultures from unprimed mice, and intranasally primed mice, with either wild-type Cry1Aa or with mutant toxin Cry1Aa8. Spleen cells from unprimed mice stimulated with Cry1Aa produced very low levels of Th1 (IFN-gamma, IL-12p70) and Th2 type cytokines (IL-10, IL-4), whereas immunization with Cry1Aa8 toxin led to higher production of these cytokines. Restimulation of spleen cells from primed mice with the Cry1Aa induced the production of significant levels of IL-12p70 whereas with Cry1Aa8, IFN-gamma production was stimulated. Interestingly, we found that the capacity of Cry1A toxins to induce cytokine production by lymphocytes was inhibited by N-acetylgalactosamine. Altogether these data demonstrate the immunogenic properties of Cry1A toxins and show that amino acid substitution in Domain I principally affects its ability to induce Th1 cytokines in lymphocytes.


Subject(s)
Bacillus thuringiensis/immunology , Bacterial Proteins/immunology , Bacterial Toxins/immunology , Diphtheria Toxin/immunology , Endotoxins/immunology , Hemolysin Proteins/immunology , Hydrophobic and Hydrophilic Interactions , Amino Acid Motifs/genetics , Amino Acid Motifs/immunology , Amino Acid Substitution/genetics , Amino Acid Substitution/immunology , Animals , Bacillus thuringiensis/genetics , Bacillus thuringiensis Toxins , Bacterial Proteins/genetics , Bacterial Toxins/genetics , Cells, Cultured , Diphtheria Toxin/genetics , Endotoxins/genetics , Hemolysin Proteins/genetics , Immunity, Cellular , Male , Mice , Mice, Inbred BALB C
SELECTION OF CITATIONS
SEARCH DETAIL
...